Feature
News from us and our partners
News
News
Capital
News
Biovelocita
News
Crossover
News
Capital
News
In Memory of Denis Lucquin
Sofinnova Partners closes €650M ($750M) Capital XI, greatly exceeding initial target to back early-stage healthcare deals
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
CEO spotlight: Thierry Abribat's third straight win
Johnson & Johnson to acquire Shockwave Medical
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
P2 Science raises $23M to expand green chemistry platform
- News
HAYA Therapeutics doses first cohort in Phase 1 trial
- News
Tulyp Medical appoints Steve Motes as CEO
- News
Baxfendy approved in the US for hypertension
- News
Sensorion appoints Fred Chereau as CEO
- News
Hemab Therapeutics closes $347M Nasdaq IPO
- News
CellCentric raises $220M Series D for inobrodib trials
- News
Signadori Bio raises €11M seed to advance tumour platform
- News
Hemab Therapeutics prices IPO at $18 per share
- News
Freya Biosciences reports positive Phase 1 data for FB301
- News
In Memory of Denis Lucquin
- News
Biotalys achieves first milestone in bioinsecticide partnership with Syngenta
- News
Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth
- News
Bioptimus Announces STELA: The World’s Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
- News
Abivax announces full year 2025 financial results and provides business updates